An international team of scientists and veterinarians was assembled in 1999 to develop a monitoring program to determine the susceptibility of cat fleas, Ctenocephalides felis felis (Bouché) (Siphonaptera: Pulicidae), to imidacloprid. Cat flea eggs were collected, shipped to laboratories, and tested for their susceptibility to imidacloprid. Over 3,000 C. felis populations were collected from 2002 to 2017 from 10 different countries. Of these, 66.3% were collected from cats and 33.7% from dogs. C. f. felis populations (n = 2,200) were bioassayed by exposing cat flea eggs and the emerging larvae to a Diagnostic Dose (DD) of 3 ppm imidacloprid in larval rearing medium. Flea eggs hatched and developed in the untreated controls in 1,837 of the isolates (83.5%) bioassayed. Flea isolates (n = 61) that had ≥5% survival at the DD of 3 ppm were retested with a second DD of 3 ppm. None of them had ≥5% survival to the second dose of 3 ppm. Of the 1,837 valid C. felis isolates tested, there has been no evidence of a decreased susceptibility to imidacloprid over the past 17 yr. The methods outlined in this article should provide an acceptable protocol for testing many of the new active ingredients that have been registered for cat flea control.
The cat flea Ctenocephalides felis felis (Bouché) (Siphonaptera: Pulicidae) is the most important ectoparasite of domestic cats and dogs worldwide and a vector of emerging zoonotic diseases. The application of insecticides to the animal and environment has been the primary control strategy for the control of cat fleas for the past six decades (Ebeling 1975; Rust 1990; Dryden 2004; Blagburn and Dryden 2009 ). With the registration of fipronil, imidacloprid, and lufenuron in the mid-1990s, a new era of oral and topical treatments for the control of fleas began. Since then, additional chemistries with different modes of action such as nicotinic acetylcholine receptors allosteric modulators (spinosad and spinetoram), oxadiazines (indoxacarb), semicarbazones (metaflumizone), and isoxazolines (afoxolaner, sarolaner, fluralaner, lotilaner) have been registered (Blagburn and Dryden 2009; Rufener et al. 2017; Rust 2017) . Many of these kill adult fleas on the host and prevent adult fleas from laying viable eggs, thereby breaking the flea life cycle.
Even though fipronil and imidacloprid have been used widely for over two decades, there have been only four published reports of possible resistance or reduced susceptibility to fipronil and imidacloprid. In one study cats were treated with fipronil spoton and challenged with a susceptible strain of cat flea and a fieldcollected isolate that had an LD 50 resistance ratio of 26 by topical application. A 24-h exposure to fipronil-treated cats provided >96% kill of susceptible fleas and only 32.6% kill of the fipronilresistant fleas when the treatments had aged 28 d (Schenker 2001) . A second report of reduced susceptibility to fipronil was observed in an evaluation of three different C. felis strains (Payne et al. 2001) . In that study when cats were treated with the maximum labeled dose of fipronil spray (15 mg/kg), it was determined that on day 30 posttreatment the efficacy against a flea strain (R6) collected from a veterinary practice in Florida was only 77.3%, whereas efficacy against two lab strains was 89.9% (KS1) and 100% (ARC). Reduced performance of fipronil has also been observed in an inhome field investigation conducted in West Central Florida (Dryden et al. 2013) . Following two monthly applications of a fipronil (s)methoprene formulation, pet flea burdens were reduced by only 54.8%, within 2 mo and only 15.6% of the dogs and cats were flea free. The efficacy observed in this study for the fipronil topical spot-on formulation was considerably less than previously observed in Florida using the same study design. In 1997, two monthly applications of a fipronil-based topical spot-on reduced flea populations on pets by 99.2% within 2 mo (Dryden et al. 2000) . Then in studies conducted in Florida in 2009 and 2010, two monthly applications of the same fipronil (s)-methoprene topical spot-on formulation reduced flea populations by 87.5 and 95.5%, respectively, within 2 mo (Dryden et al. 2011a; Dryden et al. 2011c ).
The only possible instance of imidacloprid reduced susceptibility was reported with a field-collected strain of C. felis that had low sensitivity to imidacloprid in contact exposure tests on filter paper compared with more susceptible isolates of C. felis from three other dogs (Hayashiya 2012) . A number of laboratory studies have been reported with a flea strain (KS1) that has varying degrees of reduced susceptibility to pyrethroids, organophosphates, fipronil, imidacloprid, and spinosad (Bossard et al. 1998 (Bossard et al. , 2002 Payne et al. 2001; Coles and Dryden 2014) . Interestingly, this strain was collected in 1990, several years prior to the introduction of fipronil-, imidacloprid-, or spinosad-based flea products. However, the general consensus is that most of the reports of reduced performance of the on-animal and oral therapies are largely attributed to operational aspects and treatment deficiencies (Rust 2010; Dryden et al. 2011b; Halos et al. 2014; Rust 2017 ).
An international group of scientists and veterinarians was assembled and funded by Bayer Animal Health in 1999 to form a team to monitor the susceptibility of cat fleas to imidacloprid. The objectives of the group were to develop a methodology to collect and ship cat flea populations around the world and to test them for their susceptibility to imidacloprid. This article reports the findings and conclusions of that effort from 2002 to 2017. Observations about collecting flea colonies, flea colony maintenance, testing for susceptibility, and its adaptability for testing other insecticides are discussed.
Methods and Materials

Collection of Field Samples
Veterinary clinics throughout the United States, the United Kingdom, France, Australia, and Germany were recruited to collect and send flea eggs to one of the designated research laboratories. A few collections were received from clinics in Austria, Canada, Denmark, Italy, and the Netherlands. Each clinic was provided with a kit and a detailed protocol for collecting and shipping the eggs. The kits consisted of a styrofoam shipping container, ice pack, and polyester batting. Each kit had an accompanying questionnaire requesting information concerning each cat or dog, treatment history and details of other pets in the household (Rust et al. 2005; Blagburn et al. 2006) .
To collect flea eggs, a sheet of paper or cardboard was placed on a table or floor. A cage with an open-grate floor containing an animal infested with fleas was placed over the paper. Food, water, and litter pans were provided as needed. After 4-24 h, the animal was gently brushed or combed to dislodge flea eggs. The debris and eggs were brushed to the center of the paper and poured through a sieve and funnel into a glass tube. The tube was covered with filter paper and sealed with white tape or parafilm. In the United States and Australia, tubes were placed in a styrofoam cooler with insulation, a frozen ice pack and moist gauze and sent overnight to one of the testing laboratories. In Germany, France, and the United Kingdom, where climatic conditions were often less extreme and transportation distances much shorter, tubes were wrapped in bubble wrap and posted in a special delivery envelope (Rust et al. 2005) .
A questionnaire was included with each kit (Fig. 1) . The questionnaire had been refined several times throughout the study to include more information regarding the pets, previous treatments, other pets in the household, and the condition of the flea egg collection. An insert with pictures of 20 different flea control products such as Advantage, Frontline, Program, Vectra 3D, Bravecto, and NexGard was provided to assist the pet owners in identifying products that they might have used. We report herein the most recent results from 2012 to 2016.
The testing laboratories were located at Auburn University, Auburn, AL; Bayer Animal Health laboratories in Monheim, Germany; Kansas State University, Manhattan, KS; University of Queensland, Gatton, Australia; Royal Veterinary College, Hertfordshire, United Kingdom; and University of California Riverside, Riverside, CA.
Maintenance of Flea Colonies
Laboratory susceptible strains maintained at each testing facility and field-collected isolates were maintained on separate cats according to a procedure modified from Metzger and Rust (1996) . Cat flea eggs were collected from trays beneath cats supporting each strain or isolate. The eggs and debris were passed through a series of sieves, 10, 16, 20, and 60 mesh, with the eggs being retained on the 60 mesh.
The eggs were placed on a larval rearing medium prepared at each testing facility. The medium consisted of dried beef blood, ground dog chow, inactive baker's yeast, and silica sand (30 mesh). Initially all labs were using the same larval rearing medium, but difficulties in shipping the medium internationally because it contained dried beef blood required each laboratory to prepare their own rearing medium. The eggs and medium were maintained at 26 ± 2°C and 75% relative humidity (RH). Larvae developed into pupae in 10-12 d. The pupal cocoons were screened from the medium with a 16-mesh screen and held in jars for emergence. Adults typically emerged within 16-18 d. Approximately, 30 males and 30 females were placed on cats every 2 wk to maintain each strain or fieldcollected isolate.
Larval Bioassays Diagnostic Dose
Cat flea eggs were exposed to a Diagnostic Dose (DD) of 3 ppm imidacloprid in larval rearing medium (Blagburn et al. 2006 ). Exactly 0.2 ml aliquots of 3 × 10 −5 % imidacloprid (99.9% technical, Bayer Animal Health, Monheim, Germany) were applied to 2 g of larval rearing medium in 76 × 20 mm plastic vials (Sarstedt, Newton, NC) and allowed to dry for at least 4 h before being transferred to glass petri dishes (5 cm diameter by 1.5 cm). To expedite testing, plastic vials containing treated medium were stored in the freezer (ca. −11°C) for up to 30 d. Twenty cat flea eggs of a field-collected isolate were placed on the medium and the dishes and eggs were placed in a chamber maintained at 75% RH and 26 ± 2°C. After 28 d, the number of adults that emerged was determined.
A minimum of 40 cat flea eggs was required to conduct the test with 20 eggs being exposed to the DD and 20 eggs used in the controls. If there were more than 40 eggs in a shipment, then the eggs were assigned to treatments as follows: two treatments and one control, three treatments and two controls, three treatments and two controls, four treatments and two controls, or five treatments and two controls. The controls and any eggs not used in the bioassay were reared in untreated medium.
If there was ≥5% adult emergence at the DD of 3 ppm, then the adults emerging in the untreated controls or untreated medium were placed on individual cats. The field-collected isolates were maintained on cats until sufficient numbers of flea eggs were available to conduct a second DD of 3 ppm. If there was ≥5% emergence, then a full probit analysis was conducted (modified from Blagburn et al. 2006; Fig. 2) .
Beginning in 2006, an additional test of the debris collected along with the flea eggs at the clinics was conducted by Auburn University and the Monheim lab, if the controls of the field-collected eggs failed to hatch. The debris from the collection tube was tested to determine if something toxic to flea eggs such as an insect growth regulator (IGR) might be in the field-collected samples. Twenty flea eggs from a laboratory susceptible strain were added to the debris from the collecting tube. The flea eggs and debris of the field-collected isolate were placed on untreated larval medium and placed in a chamber maintained at 75% RH and 26 ± 2°C. After 28 d, the number of adults that emerged was determined. Greater than 80% emergence was considered the threshold and emergence lower than that indicated some kind of toxic factor present. This debris test was also subsequently incorporated by the Australian laboratory when it joined the program in 2008.
Full Probit Analyses
To determine the activity of imidacloprid against field-collected isolates of cat fleas, flea eggs were exposed to larval rearing media treated with serial dilutions of imidacloprid (99.9% technical, Bayer Animal Health, Monheim, Germany). Two grams of media were placed in the bottom of each plastic Sarstedt vial and treated with 2 ml of the serial dilutions of technical imidacloprid in acetone (0.003, 0.0015, 0.001, 0.0005, 0.0003, 0.0001, 0.00005, 0.00001, and 0.000005%), providing treated medium ranging from 30 to 0.05 ppm. The mixture was stirred and the media was allowed to dry for at least 4 h. The treated medium was poured into glass petri dishes (5 cm diameter by 1.5 cm) and 10 flea eggs were added to each. The petri dishes were placed into incubators maintained at 26 ± 2°C and 75% RH. At 28 d, the number of adult fleas was counted.
Adult emergence data were analyzed by probit analysis with POLO program (Robertson and Preisler 1992) .
This study was conducted according to the Guide for the Care and Use of Laboratory Animals promulgated by the Committee on Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, National Research Council, and protocols adopted by each institution.
Results and Discussion
Flea Collections
Flea eggs were selected as the life stage to collect and ship for testing in the laboratories for several reasons. First, large numbers of adult fleas were difficult to collect. Second, adult male fleas that were removed from the host died within 2 d and females were inactive within 3 d (Dryden 1988 ). Third, larval fleas were too susceptible to desiccation and obtaining sufficient numbers of the same age was problematic. With overnight mail delivery, flea eggs arrived before they hatched and could be tested immediately. With a minimum of 40 eggs (20 treatment, 20 controls) a bioassay could be conducted. As the adults emerged in the controls, they could be used to establish a laboratory colony if desired (Blagburn et al. 2006) .
Flea eggs were collected from 10 different countries (Table 1) . A total of 3,036 flea egg collections were sent to the six different research laboratories for testing from 2002 to 2017. Not all laboratories participated every year. The greatest number of collections was from the United States and the United Kingdom and simply reflected the extra effort made by Bayer Animal Health personnel to contact clinics in each of those countries. This did not necessarily reflect the importance of cat fleas as pests in the United States, United Kingdom, or the other countries and was purely an operational factor. A more robust effort to collect samples in Australia and France began in 2010. Within the United States, 1,754 collections were made and the distribution of the samples received from the states was as follows: California (18.0%), Missouri (14.9%), North Carolina (12.0%), Florida (10.9%), Alabama (10.5%), Georgia (7.9%), Texas (7.9%), and the remaining states (17.9%). Approximately 66% of the samples were collected in southern coastal states and California. Of the 3,036 samples, 66.3% of them were collected from cats and 33.7% were collected from dogs ( Table 2 ). The collection of flea eggs from cats was much simpler and may in part explain the larger number of samples from cats compared with dogs.
The greatest number of flea egg collections from the countries in the northern hemisphere was in August, September, and October (Fig. 3) . The fewest number of collections was in March, but it is noteworthy that flea eggs were collected every month of the year. The seasonal pattern of flea egg collections in the northern hemisphere was consistent with seasonal data reported by Lyon (1915) , Osbrink and Rust (1985) , Voigt (2006) , and Rust et al. (2011) with lower numbers in the winter months (December to March) and the greatest numbers in the summer months (June to September).
In Australia, August, September, and October were also the most productive months for collecting flea egg samples (Fig. 4) . However, the pattern in the southern hemisphere was unexpected. Many of the clinics providing flea egg collections were near Brisbane. In Brisbane, the average temperatures in winter months of July, August, and September range from 16 to 19°C with low temperatures of 10-14°C. The rainfall is between 30 and 60 mm during this 3-mo period. Kern et al. (1999) reported survival of fleas outdoors in northern Florida with temperatures as low as 3 to 10°C. Brisbane's climate is more moderate than northern Florida and cat fleas were reported year round in Brisbane. In protected microhabitats in southern California, cat fleas developed when temperatures exceeded 4°C (Silverman and Rust 1983) . Cooperators in Australia relied heavily on the veterinary school's clinic that neuters pets to obtain flea isolates and this program is typically at its peak from August to October. This operational factor may explain the high prevalence of collections during the winter months.
In the southern hemisphere, seasonal patterns reflected the climatic conditions of the regions of Brazil examined. In Belo Horizonte, cat fleas were least prevalent in the warmer and drier summer months (Paz et al. 2015) . Costa-Junior et al. (2012) also reported variations in the prevalence of C. felis in Brazil that were affected by the rainy season. In coastal climates in California, seasonal trends were predictable by the following climatic conditions in their order of importance: temperature > RH > rainfall (Osbrink and Rust 1985) .
Adult fleas were collected from cats and dogs in the northern hemisphere and Australia year round supporting the recommendations of providing year-around protection against cat fleas, especially in the areas with mild winters. In the United States, almost all of the samples collected from January through April were from southern states such as Alabama, North Carolina, Florida, and Texas or California. If environmental conditions are favorable, flea populations can explode within 14-16 d.
Data from flea egg collections must be interpreted cautiously because they may not necessarily reflect the prevalence of fleas on cats and dogs or the seasonality of flea populations. Samples were not randomly collected. Collections by some clinics were often limited to those pet owners able to afford veterinary services. The collection of flea eggs by veterinary clinics was a minor aspect of their daily operation and often limited their participation. Certain clinics were able to devote additional resources to collecting flea eggs that might skew the data. Over the course of the study, a number of incentives were tried to increase the probability of collecting viable samples. Incentives to increase the numbers of flea populations collected were tried by the sponsor providing clinics with veterinary products, monetary compensation, and in-office training events. It took a concerted effort and additional resources to enlist and maintain the cooperation of veterinary clinics. The successful testing of a single cat flea isolate ultimately costs hundreds of dollars.
Questionnaires
In addition to valuable data regarding the type of pet, locality, and date collected, other information was requested on the questionnaire. The results of 401 questionnaires from 2014 to 2016 were reviewed. Of the 300 responses, 47.6% of the pet owners indicated that it was their pet's first visit to the clinic with a flea problem (Fig. 5) . Country  2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Total   Denmark  1  1  0  0  0  0  0  0  0  0  0  6  0  0  0  0  8  France  0  0  0  0  0  0  7  35  40  13  22  19  6  13  7  0  162  Germany  26  24  51  12  0  0  7  5  1  0  21  24  14  7  2  0  194  Netherlands  0  0  0  0  0  0  0  0  0  1  0  0  0  0  0  0  1  United  Kingdom   59  57  67  108  58  27  13  42  43  55  44  30  32  3  17  11  666   Austria  0  0  0  0  0  0  0  0  0  0  0  7  3  0  0  0  10  Italy  0  0  0  0  0  0  0  0  0  0  0  4  0  0  0  0  4  United States  51  68  129  78  59  34  179  230  157  86  259  220  120  54  30  0 1,754  Australia  0  0  0  0  0  0  0  9  27  71  29  13  33  34  19  0  235  Canada  0  0  0  0  0  0  0  0  1  0  0  0  0  1  0  0  2  Total  137  150  247  198  117  61  206  321  269  226  375  323  208  112  75 11 3,036 Interestingly, the vast majority of pet owners in the United States had other pets at home besides the pet visiting the clinic (Fig. 6) . No attempt was made to determine if these pets were also being treated. Of the pets visiting the clinics, 53.8% had been previously treated ( Fig. 7) . Of these pet owners, 49.1% did not remember what treatments had been applied to their pets. Of the 141 responses, a variety of products had been used to control fleas. The products or types of products reported by pet owners were as follows: products with fipronil (32.6%), products containing imidacloprid (29.1%), products containing nitenpyram (14.9%), flea collars (12.8%), shampoos (3.5%), over-the-counter products (3.5%), products containing spinosad (2.8%), and products containing selamectin (1.4%). In some cases, multiple products had been used. Results from the survey may not necessarily reflect usage patterns in each country because many of the clinics were regularly visited by Bayer Animal Health field representatives and some clinics had specific treatment protocols.
About half of the pet owners were uncertain about what products had been applied to their pets to control fleas. If insecticide resistance to new active ingredients ever becomes an issue, better education and awareness by the pet owner and record keeping by the veterinarian will be necessary to implement an IPM program that includes a rotation of insecticides. In addition, many of the pet owners, especially in the United States, had multiple pets and it is uncertain how many of them were being treated. The untreated pets may serve as a reservoir for flea populations and continual re-infestations, thereby complicating any resistance management program.
Larval Bioassays
Of the 3,036 flea isolates received, 72.5% of them (2,200) had sufficient numbers of flea eggs to conduct a DD bioassay with imidacloprid ( Fig. 8) . Of the 2,200 DD bioassays conducted, the flea eggs in the untreated control from the field-collected isolates failed to hatch in 16.6% of the bioassays and were not considered valid bioassays. There was a general decline in the number of valid bioassays from 2005 to 2010. In 2006, only 53.6% of the isolates tested were considered to be valid samples. Several factors probably contributed to varying numbers of isolates that were successfully bioassayed. It typically takes several attempts at collecting and shipping the flea eggs before clinics become proficient. The clinics were instructed to avoid shipping collections that would arrive on weekends. Adverse weather, especially dry and desiccating conditions, is detrimental to flea egg survival. Collections of flea eggs during warmer and drier summer months are often poor. There was a concern that on-animal products containing IGRs may have been applied to pets and thereby reduced the viability of flea eggs long after the adulticides failed to kill adult fleas. Of the 54 flea debris collections tested, flea eggs from laboratory colonies failed to develop in 34 (63%). Clearly, something was present in sufficient quantities to prevent eggs from hatching and developing. IGRs such as methoprene and pyriproxyfen are extremely toxic to immature fleas with quantities as low as 5 ppm providing 95% kill of second and third instars (Rust and Hemsarth 2016) . Combination products containing these IGRs may have been used to treat the pets. Our questionnaire from 2014 to 2016 also indicated such products were being used.
Of the 1,837 valid bioassays, survivorship to the DD of 3 ppm ranged from 0.0 in 2017 to 9.8% in 2006 ( Fig. 9 ). Over the period from 2012 to 2017, only 61 isolates had ≥5% survivorship to the initial DD test. In the second DD test, none of the flea isolates had ≥5% survivorship. In the second test, the survival rate of flea eggs developing into adults ranged from <0.1 to 1.6%.
To validate the algorithm (Fig. 2) , six isolates that had ≥5% survivorship on the first DD test, but <5% on the second bioassay were tested with a full probit analysis. None of the six field-collected isolates were different from the Auburn and UCR laboratory strains (modified from Rust et al. 2014 ). All of the isolates and lab strains had similar responses and there was no evidence of reduced susceptibility to imidacloprid (Fig. 10) . It was unnecessary to test any of the isolates on test animals as proposed in Figure 2 .
Insecticide resistance has been documented for organochlorine, organophosphate, carbamate, pyrethrin, and pyrethroid insecticides against cat fleas as reviewed by Bossard et al. (2002) , Coles and Dryden (2014) , and Rust (2016) . Insecticide resistance in C. felis has not been routinely evaluated and characterization of its extent and impact is limited to several publications. The alleles kdr, skdr, and rdl that are responsible for reduced susceptibility to pyrethroids and organochlorines have been identified in flea populations (Bass et al. 2004a,b; Brunet 2009 ). Flea populations from Australia and nine different states in the United States were heterozygous for kdr and skdr alleles that are responsible for pyrethroid resistance and had reduced susceptibility to permethrin (Rust et al. 2015) . Resistance to pyrethroids and carbamates has also been documented in oriental rat fleas, Xenopsylla cheopis (Rothschild) (Siphonaptera: Pulicidae) (Miarinjara and Boyer 2016) . Of 32 populations of X. cheopis tested, 26 were resistant to deltamethrin (Boyer et al. 2014 ). The appearance of resistance to pyrethroids appears to be widespread in C. felis and X. cheopis. To date, other than a few reports previously mentioned, there is little evidence that resistance has developed to the new on-animal and oral therapies. The most likely explanations for most apparent failures of these treatments appear to be operational factors such as the failure to properly apply the products, failure to treat all the pets within a household, and continuous exposure to flea populations from feral animals (Beugnet and Franc 2012; Siak and Burrows 2013; Coles and Dryden 2014; Halos et al. 2014) .
Monitoring susceptibility of cat flea populations to imidacloprid over the past 15 yr represented a major commitment of resources and effort. We are unaware of any other similar effort to monitor the activity of any parasiticide of veterinary importance. Of the 2,200 C. felis isolates tested, there was no evidence of a decreased susceptibility to imidacloprid over the past 17 yr. It is remarkable that this active ingredient is still effective against adult cat fleas.
Similar studies have not been conducted with the newer chemistries available for flea control. Baseline values of susceptibility have not been established for either adult or larval fleas. If we are to detect and respond to the potential development of insecticide resistance in cat fleas, then establishing baseline values is extremely important. The protocol outlined in this study should provide an excellent starting point for determining such baselines of activity and monitoring programs for other active ingredients.
Veterinarians need to be well equipped with scientific knowledge on the importance of regular flea control and pet owner compliance. Our questionnaires clearly indicated that pet owners failed to remember treatment histories of their pets. If insecticide resistance becomes an issue in the companion animal health sector, better education of the pet owner and record keeping by clinics will be important if appropriate integrated pest management programs are to be adopted.
